About 2,170 results
Open links in new tab
FDA Approves First Subcutaneous Infliximab Product - Center for …
FDA Approves Fifth Pegfilgrastim Biosimilar, Fylnetra
First Rituximab Biosimilar, Truxima, Launches in the United States
Canada Approves High-Concentration Humira Biosimilar
Center for Biosimilars®
FDA Approves Semglee Insulin Glargine as First Interchangeable …
FDA Approves Pfizer's Rituximab Biosimilar, Ruxience
Eli Lilly Launching Lower-Priced Authorized Generic of Its Insulin …
Despite Steep Discounts, Humira Biosimilars Are Priced More Than ...
FDA Approves First Stelara Biosimilar, Wezlana - Center for …